FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer

por Lu, Lu, Jiang, Yi-Xin, Liu, Xiao-Xia, Jin, Jin-Mei, Gu, Wen-Jie, Luan, Xin, Guan, Ying-Yun, Zhang, Li-Jun
Publicado 2023

Trimodal Therapy: A Tumor Vascular‐Targeted Interlocking Trimodal Nanosystem That Induces and Exploits Hypoxia (Adv. Sci. 8/2018)

por Luan, Xin, Guan, Ying‐Yun, Liu, Hai‐Jun, Lu, Qin, Zhao, Mei, Sun, Duxin, Lovell, Jonathan F., Sun, Peng, Chen, Hong‐Zhuan, Fang, Chao
Publicado 2018

A Tumor Vascular‐Targeted Interlocking Trimodal Nanosystem That Induces and Exploits Hypoxia

por Luan, Xin, Guan, Ying‐Yun, Liu, Hai‐Jun, Lu, Qin, Zhao, Mei, Sun, Duxin, Lovell, Jonathan F., Sun, Peng, Chen, Hong‐Zhuan, Fang, Chao
Publicado 2018

Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study

por Fang, Jie, Li, Hui, Du, Wei, Yu, Ping, Guan, Ying-Yun, Ma, Shi-Yu, Liu, Dong, Chen, Wei, Shi, Guo-Chao, Bian, Xiao-Lan
Publicado 2020

Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway

por Yang, Ting, Jiang, Yi-Xin, Wu, Ye, Lu, Dong, Huang, Rui, Wang, Long-Ling, Wang, Shi-Qi, Guan, Ying-Yun, Zhang, Hong, Luan, Xin
Publicado 2021